Home

Market Capitalization of Marksans Pharma Ltd

Image

Marksans Pharma Ltd

NSE: MARKSANS

Market Cap

₹ 10712.79 crore

Last updated on: Jan 29, 2025

Key Highlights

  • The Market Cap of Marksans Pharma Ltd is ₹ 10712 crore as of 29 Jan 25 .
  • The Latest Trading Price of Marksans Pharma Ltd is ₹ 236.4 as of 29 Jan 15:30 .
  • The dividend payouts of Marksans Pharma Ltd changed from ₹ 0.05 to ₹ 0.6 over 6 quarters. This represents a CAGR of 424.15% .
Image

Marksans Pharma Ltd

NSE: MARKSANS

Share Price

₹ 236.4

8.65 (3.80%)

stock direction

Last updated on: Jan 29, 2025

Market Price of Marksans Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Marksans Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
29 Jan 2025236.4
28 Jan 2025227.75
27 Jan 2025232.75
24 Jan 2025252.85
23 Jan 2025254.2
22 Jan 2025252.4
21 Jan 2025259.2
20 Jan 2025264.7
17 Jan 2025261.45
16 Jan 2025264.8

SWOT Analysis Of Marksans Pharma Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Marksans Pharma Ltd

Asset Value vs Market Value of Marksans Pharma Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of Market Cap

Key Valuation Metric of Marksans Pharma Ltd

No data available

No data available

Historical P/E Ratio of Marksans Pharma Ltd

No data available

* All values are in %

Historical Revenue of Marksans Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Marksans Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Marksans Pharma Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Marksans Pharma Ltd

No data available

* All values are in

About Marksans Pharma Ltd

  • Marksans Pharma Limited was formerly incorporated as Tasc Pharmaceuticals Limited in April, 1982.
  • Pursuant to the Scheme of Amalgamation, name of the Company was changed from Tasc Pharmaceuticals Limited to Marksans Pharma Limited with effect from 10th October, 2005.
  • The Company primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulation.
  • The Company's research and development facilities are located in Verna, Goa and R & D center in Navi Mumbai. In 2004-05, the Company amalgamated with M/s.
  • Marksans Pharma Limited (formerly M/s.

Marksans Pharma Ltd News Hub

Marksans Pharma announces receipt of UKMHRA approval for Fluoxetine capsules

Marksans Pharma'announced that its wholly owned subsidiary Relonchem has received Marketing Authoriz

Read more

21 Aug 24

Marksans Pharma gets EIR from USFDA for Goa facility

The inspection has been classified as voluntary action indicated (VAI) and has been closed according

Read more

20 Aug 24

Marksans Pharma's Verna unit successfully completes USFDA inspection

Marksans Pharma announced that he USFDA has issued an Establishment Inspection Report (EIR) for its

Read more

20 Aug 24

Marksans Pharma to convene AGM

Marksans Pharma announced that the Annual General Meeting (AGM) of the company will be held on 24 Se

Read more

20 Aug 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Marksans Pharma Ltd Market Cap

What is the market cap of Marksans Pharma Ltd?

As of January 30, 2025, Marksans Pharma Ltd has a market capitalization of ₹10712.79, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Marksans Pharma Ltd's market capitalization?

Marksans Pharma Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Marksans Pharma Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Marksans Pharma Ltd's market capitalization change?

Marksans Pharma Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions